Special Edition #8: Preparing For A Virtual J.P. Morgan Healthcare Conference (JPM)

Special Edition #11: Making Diversity & Inclusion A Best Business Practice

Diversity & inclusion is — and has been — an important issue for the biopharmaceutical industry. As such, we thought it would be worthwhile to gain some perspective.

Special Edition #10: What Does It Take To Start A Biopharmaceutical Company?

Considering many Life Science Leader readers daydream of starting and leading their own biopharmaceutical company someday, we thought it would be informative to host an executive virtual roundtable with three biopharmaceutical company CEOs who have done just that.

Special Edition #9: Pitching And Fundraising In The New Norm

Fundraising used to always be done in person. But then COVID hit. From those first virtual pitches that may have been just a little bit “wonky,” biopharma execs have actually become quite proficient at the process and the platforms. Three biopharma execs share some best practices of the virtual pitch.

029: The Effects Of Politics On Pharma

According to Outsourced Pharma Chief Editor, Louis Garguilo, “politics has never played a bigger role in our (global) biopharma industry.” In this episode, we talk with Louis about three of his recent editorials that touch on this subject while also discussing the current IP debate in pharma and the origins of the coronavirus.

Special Edition #8: Preparing For A Virtual J.P. Morgan Healthcare Conference (JPM)

We thought it would be interesting to have a discussion with three biopharmaceutical executives about how they are preparing for this unique 2021 JPM and how those preparations are different than what they’ve done in the past.